Filter Results:
(555)
Show Results For
- All HBS Web
(555)
- People (4)
- News (148)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(555)
- People (4)
- News (148)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
- Web
Esther Koh | MBA
Tech Fellow, I can gain the strong foundation necessary to launch such ventures in a dynamic biotech environment alongside fellow builders on campus. Tech areas of interest: Biotech, medical devices, biomaterials, drug design and... View Details
- 01 Dec 2019
- News
The Race Against Resistance
the hospital, which we can then use to price our drug appropriately,” Kimble says. Kimble and Triola also stress the importance of developing antibiotics that can be used both in a hospital setting and at... View Details
Keywords: Lisa Scanlon Mogolov
- Fast Answer
Pharmaceuticals: Pipeline
Profiles cover detailed information such as alternative names, therapeutic uses, FDA actions and licensing changes, companies associated with development of the drug, etc. To begin a search, use the function BI PHRM DEX, select... View Details
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care.... View Details
- Web
Consumer Information | MBA
Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details
- 01 Mar 2012
- News
How to Close the Health Gap
companies largely ignored the world’s poor: few new drugs were created to combat tropical diseases and TB. The needs of the developing world also were neglected by the Human Genome Project, one of the great... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
investment in math and physical sciences. Moving on to challenges Merck has faced, Gilmartin explained that new drug discovery tools have increased the speed at which its competitors can introduce new products to the marketplace, even as... View Details
- 01 Dec 2022
- News
Road to Recovery
illegal-drug addictions totaled an estimated $700 billion in direct and indirect costs, according to a 2015 report from the National Institute on Drug Abuse. DynamiCare developed an app that provides... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
more than 30 countries, Mumbai-based Piramal Group comprises companies focused on health care, life sciences, drug discovery, health care information management, financial services, specialty-glass packaging, and real estate. Recently,... View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 15 Dec 2024
- News
After Ozempic
on drug development and climate research. With investments at this scale, the foundation is positioned to do more than merely contributing to progress; it’s setting the stage for transformative changes that... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
The blind man depicted in the sculpture suffers from river blindness, a disease that ravaged countless lives in the developing world until Merck researchers discovered the breakthrough drug Mectizan. The... View Details
- 25 Apr 2014
- News
Disrupting criminal enterprises that prey on children
Kayla Brochu (MBA/JD 1999) deployed business and legal strategies to combat some of the world's worst crimes as the United Nations Office on Drugs and Crime Expert on Technology-Facilitated Child Abuse, Exploitation, and Trafficking.... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The View Details
- 08 Mar 2016
- First Look
March 8, 2016
cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details
Keywords: Sean Silverthorne
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
this case: https://cb.hbsp.harvard.edu/cbmp/product/717497-PDF-ENG Harvard Business School Case 717-498 Imprimis (D) This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill... View Details
Keywords: Sean Silverthorne
- Web
Neil Band | MBA
track in tech entrepreneurship. Tech areas of interest: I’m fascinated by the application of machine learning, distributed systems, and cryptography to economics and biology. I currently research memory optimization in deep neural network training, and reinforcement... View Details
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
programs to an investment board comprising both insiders (senior GSK executives) and outsiders (including a venture capitalist and a biotech CEO). After a three-month review period, successful teams are awarded three years worth of investment funding. Because View Details
Keywords: by Carmen Nobel